Delivery Order SPE2DB22D3501-SPE2DB25FWV09
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Irbesartan 150 mg tablets in quantities of 90 units, with a contract ceiling value of $2,260.39. This firm fixed-price delivery order, which is set to be completed by August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (quantity 90) with a ceiling value of $1,558.90. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, under a firm fixed-price contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performed the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,357.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Irbesartan 75 mg tablets in quantities of 90 units. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,035.92 to AmerisourceBergen Drug Corp for Irbesartan 75 mg tablets (90-count) on September 16, 2025, with completion anticipated by September 17, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of a generic antihypertensive medication to support federal healthcare operations. The contract is performed at the contractor's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Irbesartan 75 mg tablets in a quantity of 90 units, with a ceiling value of $5,990.86. This contract, classified as a firm fixed price delivery order with no set-aside designation, represents a competitively awarded procurement under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,867.88, is for the delivery of Irbesartan 150 mg tablets. It is a firm fixed-price contract with an ultimate completion date of May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.89 firm fixed-price delivery order is for the supply of Irbesartan 150 mg tablets. The contract has a period of performance through November 12, 2024 and does not include any set-aside requirements. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $4,223.37 firm fixed price delivery order is for the supply of 4,564,960,650 Irbesartan 150 mg tablets in quantities of 90. The award has no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,194.28 firm-fixed-price contract is for the supply of 150 mg Irbesartan tablets in 90-count bottles. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen is a significant supplier of pharmaceutical and medical products to various federal agencies and healthcare programs. Through its...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $83,200 to Amerisourcebergen Drug Corporation to supply 150mg Irbesartan tablets. As the prime contractor, Amerisourcebergen will deliver 90 count bottles of the hypertension medication to a facility in Conshohocken, Pennsylvania between July 12-13, 2023. The order was placed under an existing DLA contract vehicle to support the agency's medical supply needs. No set aside provisions or subcontractors were...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWV09Delivery Order
The Defense Logistics Agency (DLA) awarded a $5,160.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Irbesartan 150 mg on August 11, 2025, with completion due by August 12, 2025. This contract was competitively awarded with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a prime contractor through its comprehensive supply agreements with DLA and other federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this flexible contract mechanism, AmerisourceBergen Drug Corp delivers pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, fulfilling the DLA's pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/11/25 |